nootkatone has been researched along with Depression in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 2 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| An, N; Bao, JZ; Liu, WP; Wang, QQ; Xia, MH; Zhao, XH | 1 |
| He, B; Jia, Y; Li, F; Wu, B; Xiao, F; Xiong, W; Yan, T | 1 |
2 other study(ies) available for nootkatone and Depression
| Article | Year |
|---|---|
Nootkatone Improves Chronic Unpredictable Mild Stress-Induced Depressive-Like Behaviors by Repressing NF-κB/NLRP3-Mediated Neuroinflammation.
Topics: Animals; Antidepressive Agents; Depression; Disease Models, Animal; Hippocampus; Inflammasomes; Interleukin-18; Interleukin-6; Ketamine; Mice; Neuroinflammatory Diseases; NF-kappa B; NLR Family, Pyrin Domain-Containing 3 Protein; NLR Proteins; Stress, Psychological; Tumor Necrosis Factor-alpha | 2023 |
Nootkatone improves anxiety- and depression-like behavior by targeting hyperammonemia-induced oxidative stress in D-galactosamine model of liver injury.
Topics: Ammonia; Animals; Antidepressive Agents; Antioxidants; Anxiety; Behavior, Animal; Brain; Cell Survival; Chemical and Drug Induced Liver Injury; Depression; Galactosamine; Hyperammonemia; Lipopolysaccharides; Liver; Male; Malondialdehyde; Mice; Oxidative Stress; PC12 Cells; Polycyclic Sesquiterpenes; Rats | 2021 |